Wound Healing

Wound Healing & Surgical Recovery Stack

Wound healing follows four stages — hemostasis, inflammation, proliferation, and remodeling — and this stack supports each one through three peptides with complementary mechanisms. BPC-157 accelerates wound closure, improves tensile strength, and reduces excessive scarring through growth factor activation; GHK-Cu drives collagen, elastin, and glycosaminoglycan synthesis for structural quality and replaces disorganized scar tissue with more functionally normal architecture; and Thymosin Alpha-1 creates the immune environment that prevents infection while avoiding the destructive inflammatory overshoot that causes poor outcomes. Always confirm with your surgeon before beginning post-operatively.

Intermediate 8 week cycle 3 peptides Save
For educational and research purposes only. Not medical advice. This protocol describes research use, not human administration. Always consult a qualified professional.

Protocol & Dosing

Acute Post-Injury / Post-Surgery Phase (Weeks 1–4):

  • BPC-157: 500 mcg subcutaneously daily (inject near wound periphery if accessible)
  • GHK-Cu: 2 mg subcutaneously daily + topical GHK-Cu cream applied directly to healing wound 2x daily
  • Thymosin Alpha-1: 1.5 mg subcutaneously twice weekly
Consolidation Phase (Weeks 5–8):
  • BPC-157: 250 mcg subcutaneously daily
  • GHK-Cu: 1 mg subcutaneously daily + continue topical
  • Thymosin Alpha-1: 1.5 mg subcutaneously once weekly
Cycle: 8 weeks (start as soon as cleared by surgeon/physician)

Notes: Always confirm with your surgeon before beginning any peptide protocol post-operatively, particularly for open wounds. Keep all injection sites sterile. GHK-Cu topical is well-tolerated — use pharmaceutical-grade formulations only.

Calculate Doses for This Stack

Use the Peptide Oracle calculator to get exact BAC water ratios and draw amounts for every peptide in this protocol.

Open Dosage Calculator